Summary

116.68 0.63(0.54%)05/17/2024
T. Rowe Price Group Inc. (TROW)

Key Facts


1 Day1 Week1 Month3 Months6 Months1 Year5 YearsAll Time
-0.731.55-5.301.3318.204.6121.2430,055.98


Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1


Trading Data
Close111.24
Open112.63
High112.68
Low111.21
Volume669,433
Change-0.82
Change %-0.73
Avg Volume (20 Days)1,345,629
Volume/Avg Volume (20 Days) Ratio0.50
52 Week Range87.44 - 132.76
Price vs 52 Week High-16.21%
Price vs 52 Week Low27.22%
Range-1.23
Gap Up/Down-0.32
Fundamentals
Market Capitalization (Mln)26,073
EBIDTA2,519,600,128
PE Ratio14.0297
PEG Ratio6.0432
WallStreet Target Price114.80
Book Value42.4450
Earnings Per Share7.7500
EPS Estimate Current Quarter1.6000
EPS Estimate Next Quarter1.8400
EPS Estimate Current Year8.4000
EPS Estimate Next Year8.5400
Diluted EPS (TTM)7.7500
Revenues
Profit Marging0.2769
Operating Marging (TTM)0.3117
Return on asset (TTM)0.1065
Return on equity (TTM)0.1838
Revenue TTM6,460,499,968
Revenue per share TTM28.8290
Quarterly Revenue Growth (YOY)0.0770
Quarterly Earnings Growth (YOY)0.6500
Gross Profit (TTM)3,566,000,000
Dividends
Dividend Share4.8800
Dividend Yield0.0456
Valuations
Trailing PE14.0297
Forward PE14.8148
Price Sales (TTM)0.0000
Price Book (MRQ)2.7103
Revenue Enterprise Value 3.7154
EBITDA Enterprise Value9.5267
Shares
Shares Outstanding223,644,000
Shares Float218,572,881
Shares Short0
Shares Short (Prior Month)0
Shares Ratio0.00
Short Outstanding (%)0.00
Short Float (%)0.00
Insider (%)2.05
Institutions (%)76.14


05/15 12:46 EST - zacks.com
T. Rowe Price (TROW) is a Top Dividend Stock Right Now: Should You Buy?
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does T. Rowe Price (TROW) have what it takes?
05/13 10:41 EST - zacks.com
T. Rowe Price's (TROW) April AUM Declines 3.7% Sequentially
T. Rowe Price's (TROW) preliminary AUM balance for April 2024 declines 3.7% on a sequential basis.
05/08 12:04 EST - seekingalpha.com
4 Dividend Aristocrats To Buy In May Plus 4 To Watch
"Dividend Aristocrats in the S&P 500 Index… have raised their annual payouts every year for at least 25 consecutive years."--Kiplinger.com/Investing.
05/06 18:15 EST - investorplace.com
Sniper Income Investing: 3 Stocks to Set Your Set Your Sights On!
When photographing a basketball game, sometimes it works best to set the camera up under the basket to catch all the action “in the paint” rather than chase players. The same goes for hunting, as many hunters wait in deer stands or duck blinds for game to cross their paths.
05/06 07:57 EST - 247wallst.com
With 3M Out, Here Are the New Highest-Yielding Dividend Aristocrats
Investors who have followed and invested money in the top-yielding stocks in the Dividend Aristocrats may now want to reshuffle their portfolios to add the newest highest-yielding members of the exclusive group of companies.
05/01 09:00 EST - seekingalpha.com
T. Rowe Price: A Dividend Aristocrat With 25% Upside Potential
T. Rowe Price Group, Inc. is a dividend aristocrat with 37 years of steady and dependable dividend payments. The stock is in a solid technical position with potential for substantial upside and has recently bounced off strong support. The recent earnings report exceeded expectations, indicating strong fundamental performance and potential for future growth.
04/30 16:30 EST - investorplace.com
7 Dividend Aristocrats Paying Sky-High Yields: April 2024
Few investment strategies have performed as well for as long as dividend investing. Numerous studies show that buying stocks that have initiated a dividend and then increased it over time beat all other stocks on the market.
04/30 13:50 EST - investorplace.com
7 Safe Haven Stocks That Can Withstand the Market's Worst Meltdowns
Everyone needs solace in stability and development in the current turbulent market climate. These are seven unwavering businesses that are well-known for their fundamental capability to withstand market downturns.
04/30 04:01 EST - zacks.com
T. Rowe Price (TROW) Q1 Earnings Beat Estimates, AUM Rises Y/Y (Revised)
T. Rowe Price's (TROW) Q1 earnings beat estimates on increased net revenues and an improvement in AUM. A rise in cash and cash equivalents will help it continue investing.
04/29 14:29 EST - seekingalpha.com
My Best Dividend Aristocrats For May 2024
The ProShares S&P 500 Dividend Aristocrats ETF performed well in March, finishing up 4.60%. Some of these gains have been erased in April, though. I present 3 strategies that can theoretically beat the dividend aristocrat index in the long term.
04/29 12:51 EST - zacks.com
This is Why T. Rowe Price (TROW) is a Great Dividend Stock
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does T. Rowe Price (TROW) have what it takes?
04/26 12:11 EST - zacks.com
T. Rowe Price (TROW) Q1 Earnings Beat Estimates, AUM Rises Y/Y
T. Rowe Price's (TROW) Q1 earnings beat estimates on increased net revenues, an improvement in AUM and a decline in expenses. A rise in cash and cash equivalents will help it continue investing.
04/26 10:41 EST - seekingalpha.com
T. Rowe Price Group, Inc. (TROW) Q1 2024 Earnings Call Transcript
T. Rowe Price Group, Inc. (NASDAQ:TROW ) Q1 2024 Earnings Conference Call April 26, 2024 8:00 AM ET Company Participants Linsley Carruth - Director, IR Robert Sharps - President & CEO Jen Dardis - CFO & Treasurer Dee Sawyer - Head of Global Distribution Eric Veiel - Head of Global Equity & Chief Investment Officer Conference Call Participants Craig Siegenthaler - Bank of America Michael Cyprys - Morgan Stanley Daniel Fannon - Jefferies Patrick Davitt - Autonomous Research Brian Bedell - Deutsche Bank Alexander Blostein - Goldman Sachs Kenneth Worthington - JPMorgan Brennan Hawken - UBS Aidan Hall - KBW Operator Good morning. My name is Norma, and I will be your conference facilitator today.
04/26 10:36 EST - zacks.com
T. Rowe (TROW) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for T. Rowe (TROW) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
04/26 09:16 EST - zacks.com
T. Rowe Price (TROW) Q1 Earnings and Revenues Beat Estimates
T. Rowe Price (TROW) came out with quarterly earnings of $2.38 per share, beating the Zacks Consensus Estimate of $2.01 per share. This compares to earnings of $1.69 per share a year ago.
04/25 13:35 EST - seekingalpha.com
Bert's March Dividend Income Summary
March is one of the lower months for SCHD for dividend payments. Realty Income has been one of my top stock buys in 2024.
04/23 13:51 EST - zacks.com
T. Rowe Price (TROW) to Post Q1 Earnings: What to Expect?
T. Rowe Price (TROW) is expected to have witnessed an improvement in AUM in the first quarter of 2024 due to a favorable equity market performance, partially offset by net outflows.
04/23 10:21 EST - zacks.com
Gear Up for T. Rowe (TROW) Q1 Earnings: Wall Street Estimates for Key Metrics
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for T. Rowe (TROW), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2024.
04/19 11:06 EST - zacks.com
T. Rowe Price (TROW) Reports Next Week: Wall Street Expects Earnings Growth
T. Rowe (TROW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
04/15 13:00 EST - globenewswire.com
OHA is Administrative Agent & Lead Left Arranger for Acentra Health's Private Refinancing
New York, New York, April 15, 2024 (GLOBE NEWSWIRE) -- Oak Hill Advisors (“OHA”) served as Administrative Agent and Lead Left Arranger for a unitranche facility supporting the refinancing of Acentra Health (“Acentra”), a portfolio company of Carlyle. Acentra is a leading provider of technology products and services to government healthcare agencies that are essential to administering Medicaid, Medicare and other health programs at the federal and state level, including claims processing, enrollment and data analytics. OHA is the largest holder of the new financing.